Therein, miR-145, miR-204 and miR-144 exhibited a significantly decreased level in cancer cases (Fig. 1h), and survival analysis suggested that the target gene KPNA2 of miR-144 was tightly associated with prognosis of patients with breast cancer (Fig. 1f). This evidence concerns the gene KPNA2 and breast carcinoma.